FIELD: medicine, medicinal virology. SUBSTANCE: method involves the use of tomatoside solution, - triazide-(25S)--5α -3β, 22α,26-triol-26-O-b-D-glucopyranoside at final concentration 0.01%. EFFECT: broadened assortment of markers for genetic poliovirus characterization, improved method of assay.
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR OF HUMAN AND ANIMAL ENTEROVIRUSES | 1991 |
|
RU2026346C1 |
| AGENT FOR ROTAVIRUS INACTIVATION | 1992 |
|
RU2057177C1 |
| MARKER FOR ESTIMATING ATTENUATION OF POLIOMYELITIS VIRUSES | 0 |
|
SU1799598A1 |
| INHIBITOR OF ROTAVIRUSES | 1993 |
|
RU2046139C1 |
| METHOD OF INTRA-TYPE DIFFERENTIATION OF POLYO VIRUSES | 0 |
|
SU1583441A1 |
| NUTRIENT MEDIUM FOR HUMAN AND ANIMAL CELLS CULTIVATION | 1992 |
|
RU2057176C1 |
| INACTIVATED POLIO VACCINE | 2011 |
|
RU2599453C2 |
| METHOD OF PREPARING STEROID GLYCOSIDES OF FUROSTANE ORDER ENHANCING GERMINATING CAPACITY, SEED ENERGY GERMINATION AND PRODUCTIVITY OF EGGPLANT | 1991 |
|
RU2035469C1 |
| METHOD OF SELECTION OF COLD RESISTANT CORN GENOTYPES | 1992 |
|
RU2045890C1 |
| COMBINED VACCINE CONTAINING DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, HAEMOPHILUS INFLUENZAE AND POLIOVIRUS ANTIGENS, USING IT AND METHOD FOR PREPARING IT | 2009 |
|
RU2526214C2 |
